Superiority of the ear pinna over muscle tissue as site for DNA vaccination

被引:59
作者
Forg, P [1 ]
von Hoegen, P [1 ]
Dalemans, W [1 ]
Schirrmacher, V [1 ]
机构
[1] German Canc Res Ctr DKFZ, Div Cellular Immunol, D-69120 Heidelberg, Germany
关键词
lacZ gene; promoter; tumor; immunity; genetic immunization;
D O I
10.1038/sj.gt.3300628
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Three different vaccination sites were compared for efficiency of immunization with naked DNA. Using the bacterial lacZ gene as a model, all three sites of the mouse (skeletal muscle, dermis of abdominal skin or of the ear pinna) could express the gene product beta-gal but varied in expression time with muscle tissue showing the longest expression. Expression time, however, did not correlate with immune response intensity. Th ear pinna was by far the most effective and muscle the least effective priming site for specific humoral and cytotoxic T cell-mediated immune responses. Following intra-pinna DNA inoculation, beta-gal expressing cells were detectable around the injection site and in the major draining lymph node. Efficiency of immunization was also dependent on the promoter and expression vector used. The cytomegalus virus promoter driven pCMV beta vector was superior to the Moloney murine leukemia virus LTR driven BAG vector. LacZ DNA immunization was also compared with cell-based vaccination with lacZ-transfected tumor cells, in which case again the pinna was the best site for inducing strong immune responses. Tumor-specific T cell responses could also be well induced in the pinna, leading to cytotoxic T lymphocyte induction and protective antitumor immunity. Thus, the pinna was found to be a privileged site for induction of antitumor responses and for genetic immunization, an important finding of immediate practical and potential future clinical implications.
引用
收藏
页码:789 / 797
页数:9
相关论文
共 39 条
[1]   DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocyte and antibody responses in mice after intramuscular injection [J].
Bohm, W ;
Kuhrober, A ;
Paier, T ;
Mertens, T ;
Reimann, J ;
Schirmbeck, R .
JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 193 (01) :29-40
[2]   CLASS-I-RESTRICTED PROCESSING AND PRESENTATION OF EXOGENOUS CELL-ASSOCIATED ANTIGEN INVIVO [J].
CARBONE, FR ;
BEVAN, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (02) :377-387
[3]   INVIVO PROMOTER ACTIVITY AND TRANSGENE EXPRESSION IN MAMMALIAN SOMATIC TISSUES EVALUATED BY USING PARTICLE BOMBARDMENT [J].
CHENG, L ;
ZIEGELHOFFER, PR ;
YANG, NS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (10) :4455-4459
[4]   Puncture-mediated gene transfer to the skin [J].
Ciernik, IF ;
Krayenbuhl, BH ;
Carbone, DP .
HUMAN GENE THERAPY, 1996, 7 (08) :893-899
[5]   DNA-based immunization by in vivo transfection of dendritic cells [J].
Condon, C ;
Watkins, SC ;
Celluzzi, CM ;
Thompson, K ;
Falo, LD .
NATURE MEDICINE, 1996, 2 (10) :1122-1128
[6]  
CONRY RM, 1994, CANCER RES, V54, P1164
[7]   Gene vaccination with naked plasmid DNA: Mechanism of CTL priming [J].
Corr, M ;
Lee, DJ ;
Carson, DA ;
Tighe, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) :1555-1560
[8]   DNA-BASED IMMUNIZATION INDUCES CONTINUOUS SECRETION OF HEPATITIS-B SURFACE-ANTIGEN AND HIGH-LEVELS OF CIRCULATING ANTIBODY [J].
DAVIS, HL ;
MICHEL, ML ;
WHALEN, RG .
HUMAN MOLECULAR GENETICS, 1993, 2 (11) :1847-1851
[9]   DIRECT GENE-TRANSFER INTO SKELETAL-MUSCLE INVIVO - FACTORS AFFECTING EFFICIENCY OF TRANSFER AND STABILITY OF EXPRESSION [J].
DAVIS, HL ;
WHALEN, RG ;
DEMENEIX, BA .
HUMAN GENE THERAPY, 1993, 4 (02) :151-159
[10]   Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells [J].
Doe, B ;
Selby, M ;
Barnett, S ;
Baenziger, J ;
Walker, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) :8578-8583